SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (1296)6/18/1998 8:46:00 PM
From: macker  Read Replies (2) of 5402
 
the 30 mm is not just for animal trials but what is being committed to the project in bits and pieces as a long term umbrella package should they ever get to fda trial stages that require the big funding. but i agree with you, they will never get this product to market as i believe that they will get bought along with their technology well before they could get to market. batelle will draw a lot of attention to sgnc, i still dont believe this stock is a "get the product to market play", rather it is a somatogen style play of getting enough exposure to get the big boy to buy them out. they will never come remotely close to having enough money to manufacture or market such a product, like other prominent biotech's with a good technology, they are banking on a buyout.

i think that this is one of the reasons that batelle is wanting a piece of the action so bad, they know that they have a diamond in the rough here. i appreciate your post here andrew, good insight.

macker
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News